About HIRF
  1. Mission
  2. Management
  3. History
  4. Affiliates

About ICVS

  • 2001 Tokyo
  • 2003 Beijing
  • 2004 London
  • 2006 Washington DC
  • 2007 Vienna
  • 2008 New York
Grant Programs
  • Clinical Trials
  • Education
  • Training
  • Publication

Recommended Links

Contact HIRF


Professor Georg STINGL (2002, 2003, 2004, 2006)

Georg Stingl, MD was born in 1948 and graduated from the University of Vienna Medical School in 1973. He received his dermatological and basic immunological training at the Departments of Dermatology I and Immunology of ViennaLs University.

In order to pursue his interest in immunologically mediated skin diseases as well as in the cellular interactions occurring during the immune response, he obtained a grant for an 18-month fellowship at the Dermatology Branch, National Cancer Institute, Bethesda, MD, U.S.A. Under the guidance of Drs. Stephen I. Katz, Dean L. Mann, Ira Green and Ethan M. Shevach he studied the phenotypic and functional features of epidermal Langerhans cells. In 1978, Dr. Stingl moved to the Department of Dermatology, University of Innsbruck Medical School, Austria where he established an independent research program. In 1980, he was promoted to the rank of Associate Professor of Dermatology. Upon his return to the Department of Dermatology I, University of Vienna Medical School in 1981, he was appointed Director of the Immunology Unit by the Department Chairman. After he became a Full Professor of Dermatology in 1985, he spent a sabbatical year at the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD. During this time, he received basic training in molecular biology and applied this technology to the clarification of the lineage of certain epidermal leukocytes. In 1991, he was appointed Professor and Chairman of the Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, University of Vienna Medical School which now consists of 30 physicians and staff scientists.

Dr. Stingl's research interests have centered on the exploration of the skin immune system under both physiological and pathological conditions, on the interaction between the human immunodeficiency virus (HIV) and cutaneous leukocytes, on the pathogenesis of atopic dermatitis as well as on the use of genetically engineered cancer vaccines as therapeutic tools for metastasizing melanoma and of a new series of topically applied immunomodulators in the treatment of inflammatory and neoplastic skin diseases.

Dr. Stingl is member of the Austrian and German Academies of Sciences and has received several prestigious research awards such as the William Montagna Award and the Stephen Rothman Award from the Society for Investigative Dermatology (SID). In 1999, he received the Honorary Doctorate from the Semmelweis Medical University in Budapest.

Dr. Stingl was President of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), the European Dermatology Forum (EDF), the European Society for Dermatological Research (ESDR) and served as the ESDR Deputy Editor of the Journal of Investigative Dermatology. He is currently the Secretary General of the International League of Dermatological Societies (ILDS) and Member of the Board of the Austrian Academy of Sciences. Dr. Stingl lives in Vienna.